Standard Controlled Clinical Study to evaluate the effect of Vidangadi Choorna in the management of Vataja Kasa W.S.R to Tropical Pulmonary Eosinophilia

Background: Tropical Pulmonary Eosinophilia (TPE) occurs predominantly in males with male : female ratio of 4:1, it’s seen more between the age group of 15-40 years and is considered to be endemic in India. Attempts to co-relate Vataja Kasa (type of Cough due to Vata humor) to Tropical Pulmonary Eosinophilia have been done by many researchers. Usage of Vidangadi Choorna in Vataja Kasa has been highlighted in the classics of Ayurveda, which has not been evaluated yet. Objectives: The present study was intended to evaluate and compare the efficacy of Vidangadi Choorna and Kantakari Gritha (as a standard drug) in near equal groups relating to raised AEC and Vataja Kasa symptoms. Materials and Methods: 30 patients were enrolled in the study and were treated with the above drugs for the duration of thirty days with the focus on reliving of symptoms and management of the disease. Observations and results: In the present study, Vidangadi Choorna and Kantakari Gritha both were beneficial in reducing the symptoms of Vataja Kasa (TPE). On comparisons between the groups, Vidangadi Choorna was more beneficial in reducing Absolute Eosinophilic count compared to Kantakari Gritha. Although both the groups showed highly significant results in symptoms, patients on Vidangadi Choorna expressed greater benefit compared to Kantakari Gritha. Conclusion: Vidangadi Churna was more beneficial in reducing Absolute Eosinophilic count compared to Kantakari Gritha.